GG 623 GG 623 (Terazosin 5 mg)

Pill with imprint GG 623 GG 623 is Pink, Capsule-shape and has been identified as Terazosin hydrochloride 5 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for GG 623 GG 623

Terazosin hydrochloride

Imprint:

GG 623 GG 623

Strength:

5 mg

Color:

Pink

Size:

16.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antiadrenergic agents, peripherally acting

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Sandoz Pharmaceuticals Inc.

Inactive Ingredients:

corn starch
crospovidone
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
gelatin
lactose monohydrate
magnesium stearate
microcrystalline cellulose
shellac
propylene glycol
ferrosoferric oxide
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
00904-6128	Major Pharmaceuticals
54569-4875	A-S Medication Solutions, LLC (repackager)
54868-4248	Physicians Total Care Inc. (repackager)
67544-0084	Prepak Systems Inc. (repackager)

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.